Navigation Links
Political decisions harming cancer treatment in Europe
Date:9/24/2007

Barcelona, Spain: Recent political decisions have had serious consequences for European oncology, said Professor John Smyth at ECCO 14, the European Cancer Conference, today (Monday 24 September 2007). Professor Smyth, President of the Federation of European Cancer Societies (FECS) said that the new European CanCer Organisation (ECCO) would take an active role in engaging with policymakers to ensure that future legislation did not have a similarly negative impact.

Professor Smyth cited the Clinical Trials Directive and the recent Directive on Physical Agents (Electromagnetic Fields) as two examples of legislation that had had a major negative impact on oncology in Europe. In the first, the academic oncology community woke up too late and found that the administrative and financial burden of running clinical trials had increased to the extent that many simply gave up, he said. Now the Directive on Electromagnetic Fields looks as though it may stop all MRI scanning in Europe. We simply cannot continue to bury our heads in the sand on these issues, which affect doctors and patients alike.

Forthcoming topics of concern were the problems of international collaboration on stem cell research where European countries had widely differing legislation, and the whole area of the escalating cost of cancer treatment. The successful development of many new anti-cancer drugs in recent years is challenging every health economic programme in Europe, said Professor Smyth. It is imperative to find ways to improve the cost effectiveness of cancer treatment in general, and particularly the use of drugs. Improving the cost effective use of medicines is a major priority for industry, politicians and the public at large.

Due to these new and improved treatments, screening, and earlier and better diagnosis, cancer patients are living longer and better lives. But how will the huge financial burden on society that this implies be met" ECCO will be asking governments and the European Commission to consider these issues as a matter or urgency.

ECCO will bring together major players in cancer research, treatment, and care in order to create awareness of patients wishes and needs, encourage progressive thinking in cancer policy, education, and training, and continue to promote European cancer research and its application through the organisation of multi-disciplinary meetings and conferences, he said.

The difference between the new ECCO and the old FECS will be that the new organisation has decided to take a far more active role in engaging with policymakers to promote the interests of both cancer patients, those who care for them; and those without whose research there would be no advances in treatment and care, he said. For too long oncologists have sat back and said that getting involved in politics is not their business, and recent events have shown us that this is an attitude which is no longer sustainable.

The last two years had given ample opportunity for reflection, said Professor Smyth. Not only did we consult our members, but we also carried out an audit of many players in oncology, patient groups, media, and other stakeholders. They all told us the same thing they wanted to see a democratic, representative, and visionary organisation tackle the problems that are currently besetting oncology science and practice. An organisation that would provide consistently dependable information on the state of oncology in Europe, and through that information provision would strive to improve the lot of everyone involved in cancer.

It is a daunting task, but one that needs to be undertaken. And we will do our very best to carry it out.


'/>"/>

Contact: Mary Rice
mary@mrcommunication.org
Federation of European Cancer Societies
Source:Eurekalert

Related medicine news :

1. FDA Decision To Reject Plan B Made Under Political Pressure: Officials
2. Tuberculosis, A Challenge To The Political Will Of Governments, Says Veteran Crusader
3. People suffering from Alzheimer’s: can they take decisions about their treatment
4. Decisions On End-of-Life Treatment Found To Vary From Country To Country
5. Doctors decisions are affected by fear of lawsuits- says a study
6. Pharma Companies May Influence The Decisions Of Medical Students
7. Critical Decisions Have To Be Taken By Mothers Of Premature Babies
8. Distinct Brain Sections Are Activated While Making Risky Decisions
9. Image-Guided Biopsy Can Alter Clinical Decisions In Kidney Patients
10. Insight Into The Risky Health Decisions On Bird Flu
11. Fair Sex Thought to Fare Well with Medical Decisions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... ... January 17, 2017 , ... Recently, patients and staff ... Michigan, joined other volunteers and organizations in support of the annual Binder Park Zoo ... families dressed up in colorful costumes of all designs coming out to enjoy games, ...
(Date:1/16/2017)... ... , ... With the Grand Opening Event planned for February 3, 2017, the ... and the general public. Built in five months by Centerpoint, the 60,000 square foot ... or pickleball courts. The space is also suitable for indoor soccer and football training. ...
(Date:1/16/2017)... ... January 16, 2017 , ... Permobil has ... Reflection® brand of custom seating systems has a well-earned reputation for premium quality, ... platform for innovation and growth in the custom seating business, which enjoys strong ...
(Date:1/16/2017)... ... January 16, 2017 , ... Date aired: ... http://www.ageofautism.com/legal , Sharon Kleyne, America’s leading water educator, researcher and advocate welcomed ... radio program, The Sharon Kleyne Hour Power of Water, Global Climate Change and ...
(Date:1/16/2017)... Francisco, CA (PRWEB) , ... January 16, 2017 , ... ... incorporation of iTero Element, the latest in 3-D scanning device which is capable of ... of the latest advances in dentistry, such as CAD CAM restorations , in ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)... , Jan. 16, 2017 Derek H. ... Law Firm, was recently appointed Liaison Counsel in ... for all Xarelto cases. In this role, Potts was ... and will actively assist the Court and Co Lead ... Milstein Adelman Jackson Fairchild & Wade ...
(Date:1/16/2017)... , Jan. 16, 2017  Harrington Discovery ... Ohio – part of The Harrington ... its 2016 partnership Scholars selected in collaboration with ... Blindness and University of Oxford. ... shared mission to advance discoveries into new medicines ...
(Date:1/16/2017)... ROCKVILLE, Md. , Jan. 16, 2017 /PRNewswire/ ... tomography (CT) systems market is valued at $4.9 ... applications for CT, coupled with an aging population ... incidence of chronic disease, is propelling the market ... report, Computed Tomography Markets , focuses on ...
Breaking Medicine Technology: